IONS
Ionis Pharmaceuticals, Inc.
$40.91
Earnings Summary
Revenue | $324.51Mn |
Net Profits | $-9.26Mn |
Net Profit Margins | -2.85% |
Highlights
Ionis Pharmaceuticals, Inc.’s revenue jumped 113.49% since last year same period to $324.51Mn in the Q4 2023. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 125.35% jump in its revenue since last 3-months.
Ionis Pharmaceuticals, Inc.’s net profit jumped 82.19% since last year same period to $-9.26Mn in the Q4 2023. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 93.7% jump in its net profits since last 3-months.
Ionis Pharmaceuticals, Inc.’s net profit margin jumped 91.66% since last year same period to -2.85% in the Q4 2023. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 97.2% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Ionis Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -1.03 |
EPS Estimate Current Year | -1.03 |
Highlights
Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.03 - a -24.1% fall from last quarter’s estimates.
Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.03.
Key Ratios
Key ratios of the Ionis Pharmaceuticals, Inc. post its Q4 2023 earnings
Earning Per Share (EPS) | -0.06 |
Highlights
Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 95.59% since last year same period to -0.06 in the Q4 2023. This indicates that the Ionis Pharmaceuticals, Inc. has generated 95.59% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-09 | -0.9 | -0.6 | 33.33% |
2024-02-21 | -0.83 | -0.06 | 92.77% |
2023-11-02 | -1.04 | -1.03 | 0.96% |
2023-05-03 | -0.91 | -0.87 | 4.4% |
₹0 US Stocks a/c Opening Fee